Results

Total Results: 1,147 records

Showing results for "event".

121. Evidence Summary: Thyroid Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/thyroid-cancer-screening
     May 09, 2017 - Text Description Figure 3 is a forest plot depicting the event rate of permanent hypoparathyroidism … Key Question 5 Results: Permanent Hypoparathyroidism From Surgery (Event), Stratified by Type of Lymph … Text Description Figure 4 is a forest plot depicting the event rate of permanent hypoparathyroidism … Key Question 5 Results: Permanent Recurrent Laryngeal Nerve Palsy From Surgery (Event), Stratified by … Key Question 5 Results: Permanent Recurrent Laryngeal Nerve Palsy From Surgery (Event), Stratified by

122. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rn7dRezgMx5syB-erQKoKt
     November 01, 2022 - Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons Updated Evidence Report and Systematic Review f…

123. PII: S0749-3797(01)00255-0 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
     January 01, 2001 - life-years and is second only to injuries as a cause of life-years lost.4 The lifetime risk of having a CHD event … Nonfatal MI, CHD death Nonfatal MI, CHD death Nonfatal MI, CHD death, unstable angina Cumulative event … 95% CI) (3–32)d (8–53) (17–43) (21–50) aEvent rates are cumulative incidence in percentages for the event … for LRC. cUnstable angina excluded in results. dCI for LRC was 90%. eNNT for 5 years to prevent 1 CHD event … primary prevention, and we have insufficient long-term data to measure the longitudinal effects of CHD event

124. Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/wdxHdZ2U5ggjuNW-nwun8n
     October 01, 2009 - classified as high-risk by each model, then assess whether the agreement between the predicted and actual event … In most studies, however, we used average annual event rates and the prevalence of the Framingham risk … In that study, participants with CAC scores of 300 or greater had the event rate of a high-risk group

125. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2008
     December 30, 2013 - heart disease will realize a small benefit from treatment, as seen inthe risk reduction in 10-year CHD event … disease was 59% lower than the rate in 1950. 2 The lifetime risk of having a coronary heart disease event … conflicting results, with some studies showing no benefit and others showing some coronary heart disease event

126. Recommendation: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening
     July 18, 2023 - Hazard ratios for a fatal cardiovascular event in adulthood were 1.30 (95% CI, 1.14-1.47) per unit increase … health outcome in the third or fourth decade of life, which may be too early to detect a cardiovascular event

127. Final Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     September 26, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring September 26, 2024 Recommendations made by the USPSTF are i…

128. Archived: C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors
     July 15, 2008 - archived C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Coronary Heart Disease: Screening Using Non-Traditional Risk Factors July 15, 2008 Recommendations made by the USPSTF are independent of the U.S. …

129. Archived: C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     July 15, 2008 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Coronary Heart Disease: S…

130. Archived: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-screening-using-non-traditional-risk-factors
     October 15, 2009 - pooled data from 6 of these studies showed a risk ratio of 1.24 (CI, 1.01 to 1.51) for any CHD or CVD event

131. Archived: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     October 15, 2009 - pooled data from 6 of these studies showed a risk ratio of 1.24 (CI, 1.01 to 1.51) for any CHD or CVD event

132. Ninth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
     January 01, 2019 - diabetes, hypertension, or smoking); and 3) they have a calculated 10-year risk of a cardiovascular event … Identification of dyslipidemia and calculation of 10-year CVD event risk requires universal lipids … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected

133. Draft Research Plan: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     May 23, 2019 - in progress Draft Research Plan Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication May 23, 2019 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the A…

134. Draft Research Plan: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/lipid-disorders-children-adolescents-screening
     May 13, 2021 - Share to Facebook Share to Twitter Share to WhatsApp Share to E-mail Print in progress Draft Research Plan Lipid Disorders in Children and Adolescents: Screening May 13, 2021 Recommendations made by the USPSTF …

135. Final Research Plan: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     September 03, 2015 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors September 03, 2015 Recommendations made by the USPSTF are independent of the U.S. gov…

136. Szn5Hhs8W5Sar6Bbpabsab (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
     June 01, 2008 - A substantial proportion of persons presenting with a new cardiovascular event have undiagnosed diabetes … the non- diabetes subgroup benefited from statin treatment in re- ducing mortality or cardiovascular event … This fair-quality study was stopped early, with a resultant low event rate in both groups. … Diabetes Prevention Program) (36), neither the cumulative incidence of cardiovascular disease nor the event … 1 Eye (Screening 1000 People with Given Prevalence) Tight Blood Pressure Control to Prevent 1 CVD Event

137. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - A substantial proportion of persons presenting with a new cardiovascular event have undiagnosed diabetes … nor the nondiabetes subgroup benefited from statin treatment in reducing mortality or cardiovascular event … This fair-quality study was stopped early, with a resultant low event rate in both groups. … Diabetes Prevention Program) 36 , neither the cumulative incidence of cardiovascular disease nor the event … Cumulative incidence of CVD and CVD event rate: NSD among groups, but underpowered for this outcome.

138. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/khUSqr94jqWPErt9ZRnQ95
     October 01, 2009 - C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force David I. Buckley, MD, MPH;…

139. Evidence Summary: Prediabetes and Type 2 Diabetes in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prediabetes-type2-diabetes-children-adolescents-screening
     September 13, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Prediabetes and Type 2 Diabetes in Children and Adolescents: Screening September 13, 2022 Recommendations made by the USPSTF are independent of the U.S. governme…

140. Draft Recommendation: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     May 04, 2021 - =107,772) after 3 to 10 years of followup or on the composite outcome of any cardiovascular disease event … 0.96 [95% CI, 0.86 to 1.07]; 7 trials; n=74,617), the composite outcome of any cardiovascular disease event … Event rates for cardiovascular disease mortality and cardiovascular disease events were too low to draw